Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

WS6 - Data Integration

In this section

The Bio-medical Research Council (BRC), a part of the Oxford Hospital Radcliffe Trust (OHRT), funds research and many of our staff are involved in BRC research.

Our research is funded from a variety of funders. Their support allows our research to focus on the basic and clinical research domains to accelerate knowledge translation from the bedside to the bench, and back again.

Work Strand 6 focuses on data integration

wtchg clusterA unique aspect of the STOP-HCV consortium is the availability of complimentary datasets on a common set of samples. This allows for integrative analysis, using all of the data for improved scientific understanding of the mechanisms underlying heterogeneity of disease susceptibility and progression, as well as host-viral interaction and implications for therapeutic response.

The joint data will also enable an integrative approach to biomarker panel construction using genetic, genomic, and serum marker data, informed by the in vitro immunity experiments.

The objective of this Work Strand is to undertake integrative analysis of the information generated by Work Strands 2 – 5 to enable prediction models to be designed.

This Work Strand is led by Professor Chris Holmes (University of Oxford).